Peter Jenkins

Specializing in global corporate development and finance, Peter has focused on the pharmaceutical marketplace for the last 20+ years of his storied career. He co-founded QuVa Pharma in 2015 with long-standing business partner Stuart Hinchen. Under their leadership, the firm has experienced consistent year-over-year growth and is still rapidly expanding.

Prior to QuVa, the two co-founded JHP Pharmaceuticals, where Peter served as CEO from 2007-2010 and CDO from 2011-2014, increasing JHP’s portfolio through development and manufacturing partnerships. He helped establish JHP as a leading injectable pharmaceutical company before selling the company in 2014.

Previously, Peter served as CDO of Mayne Group and a Director of Mayne Pharma, where he was instrumental in the acquisition of the largest sterile compounding business in the UK and the acquisition and construction of several FDA-approved pharmaceutical manufacturing facilities. During his tenure, he managed business and product development groups in the U.S., Europe, India, and Australia, and was responsible for all corporate development activities.